Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032376 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yulia Desheva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, Federal State Budgetary Scientific Institution, Institute of Experimental Medicine, 197022 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A Virus, H1N1 Subtype, Orthomyxoviridae Infections, Influenza Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Foundation for Basic Research, National Science Council of Taiwan.
Abstract (Originalsprache)
Neuraminidase (NA)-based immunity to influenza can be useful for protecting against novel antigenic variants. To develop safe and effective tools to assess NA-based immunity, we generated a baculovirus-based pseudotyped virus, N1-Bac, that expresses the full-length NA of the influenza A/California/07/2009 (H1N1)pdm09 strain. We evaluated the level of NA-inhibiting (NI) antibodies in the paired blood sera of influenza patients by means of an enzyme-linked lectin assay (ELLA) using the influenza virus or N1-Bac. Additionally, we evaluated the level of NA antibodies by means of the enzyme-linked immunosorbent assay (ELISA) with an N1-expressing Sf21 culture. We detected a strong correlation between our results from using the influenza virus and NA-Bac pseudoviruses to detect NI antibodies and a medium-strong correlation between NI antibodies and NA antibodies determined by an N1-cell ELISA, indicating that baculovirus-based platforms can be successfully used to evaluate NI or NA antibodies. Furthermore, animal experiments showed that immunization with N1-Bac protected against infection with a drift variant of the A/H1N1pdm09 influenza virus. Our results demonstrate that recombinant baculovirus can be an effective influenza pseudotype to evaluate influenza serologic immunity and protect against influenza virus infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology Department, Federal State Budgetary Scientific Institution, Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.
- Clinical Infectious Diseases Hospital No. 30 Named after S.P. Botkin, 195067 Saint Petersburg, Russia.
- Medical Center, St. Petersburg Research Institute of Epidemiology and Microbiology Named after Pasteur, 197101 Saint Petersburg, Russia.
- Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
- Department of Entomology, National Chung-Hsing University, Taichung 402, Taiwan.
- Department of Entomology, National Taiwan University, Taipei 106, Taiwan.
ORCID-Profile: Yulia Desheva, Igor Losev
Förderung
- Russian Foundation for Basic Research
- National Science Council of Taiwan
Zitieren
APA
Desheva, Y., Petkova, N., Losev, I., Guzhov, D., Go, A., Chao, Y. C., & Tsai, C. H. (2023). Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032376
Vancouver
Desheva Y, Petkova N, Losev I, Guzhov D, Go A, Chao YC, et al. Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032376
BibTeX
@article{Desheva2023,
author = {Desheva, Yulia and Petkova, Nadezhda and Losev, Igor and Guzhov, Dmitry and Go, Alexey and Chao, Yu-Chan and Tsai, Chih-Hsuan},
title = {Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032376}
}
EUVIMED